Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Felix Gerhard Maria Dietlein, M.D., Ph.D.

Concepts (174)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Fluorine Radioisotopes320204741.390 Why?
Glutamate Carboxypeptidase II22020860.980 Why?
Prostatic Neoplasms82021104390.930 Why?
Gallium Radioisotopes520211450.840 Why?
Oligopeptides3201913050.710 Why?
Antigens, Surface2202019040.680 Why?
Urea220164450.680 Why?
Nucleotides120204240.680 Why?
Niacinamide120194230.670 Why?
DNA Repair4202020350.660 Why?
Lysine3201610360.600 Why?
DNA-Activated Protein Kinase120141120.530 Why?
Edetic Acid320192980.500 Why?
Organometallic Compounds120166700.500 Why?
DNA Repair Enzymes120143730.470 Why?
Neoplasm Recurrence, Local3202086100.460 Why?
Gallium Isotopes3202140.450 Why?
Drug Synergism2201819390.450 Why?
Antineoplastic Agents, Hormonal1202015420.440 Why?
Neoplasms72021195380.430 Why?
ras Proteins1201511410.390 Why?
Protein Kinases1201517060.340 Why?
Kallikreins220202780.330 Why?
Computational Biology1202036120.320 Why?
Prostate-Specific Antigen4202122110.320 Why?
Tissue Distribution3202124810.320 Why?
Antineoplastic Agents52018138980.310 Why?
Enzyme Inhibitors2201539980.310 Why?
Mutation52020288480.290 Why?
Receptor, Fibroblast Growth Factor, Type 1220182570.280 Why?
Intracellular Signaling Peptides and Proteins1201530060.270 Why?
Proteins1202062640.270 Why?
Kidney1201967440.270 Why?
Ligands3201931890.260 Why?
Signal Transduction62020243510.250 Why?
Radiopharmaceuticals3202026970.250 Why?
Proto-Oncogene Proteins1201547160.230 Why?
Colonic Neoplasms1201425450.230 Why?
Small Cell Lung Carcinoma220183350.230 Why?
Adenocarcinoma2202064500.220 Why?
DNA Repair-Deficiency Disorders12020290.220 Why?
Receptor, EphA212020420.210 Why?
Apoptosis32016102610.200 Why?
Genomics2202149210.190 Why?
Neurofibromin 1120202020.190 Why?
Proto-Oncogene Proteins p21(ras)2201815830.190 Why?
Nuclear Proteins2201760090.190 Why?
Lung Neoplasms62020120090.190 Why?
Gene Fusion120213560.180 Why?
Proto-Oncogene Proteins B-raf2202018850.180 Why?
Whole Body Imaging120192740.170 Why?
GTP Phosphohydrolases120205070.170 Why?
Isotope Labeling120194660.170 Why?
Vascular Endothelial Growth Factor Receptor-2120205790.160 Why?
Cell Line, Tumor82021172510.160 Why?
DNA Damage3201625070.160 Why?
Propranolol120185280.150 Why?
Serine120208480.150 Why?
Carcinoma, Non-Small-Cell Lung3202046170.150 Why?
DNA-Binding Proteins1201499340.150 Why?
Parkinsonian Disorders120182560.150 Why?
Vascular Endothelial Growth Factor Receptor-1120185750.140 Why?
Germany120168520.140 Why?
Molecular Targeted Therapy2201728840.130 Why?
Cysteine Endopeptidases120166820.120 Why?
Positron-Emission Tomography3202159810.120 Why?
Humans2720216866630.120 Why?
Cluster Analysis1202027760.120 Why?
Melanoma2202055050.120 Why?
Androgen Antagonists1202112700.120 Why?
Cell Survival2202162880.120 Why?
Neoplasms, Experimental2201814160.110 Why?
Adrenergic beta-Antagonists1201812500.110 Why?
Stomach Neoplasms1202012310.110 Why?
Neoplasm Transplantation1201522960.110 Why?
Recurrence2201981980.100 Why?
Protein Kinase Inhibitors2201752520.100 Why?
Male1320213524650.100 Why?
Gene Amplification1201310940.090 Why?
Xenograft Model Antitumor Assays2201538810.090 Why?
Drug Design1201411500.090 Why?
RNA-Binding Proteins1201819610.090 Why?
Mice92021808030.090 Why?
Angiogenesis Inhibitors1201820940.080 Why?
Reproducibility of Results22016193080.080 Why?
Vascular Endothelial Growth Factor A1201834290.080 Why?
Animals1120211708490.080 Why?
Tumor Cells, Cultured1201568350.080 Why?
Bayes Theorem1201318480.080 Why?
Tumor Suppressor Protein p531201629120.070 Why?
Genome1201316810.070 Why?
Neoplasm Staging12020112650.070 Why?
DNA Copy Number Variations1201317700.070 Why?
Skin Neoplasms2202053540.070 Why?
Aged520201622710.070 Why?
Cell Transformation, Neoplastic1201330530.060 Why?
Membrane Proteins1202082620.060 Why?
Disease Models, Animal32018184950.060 Why?
Sequence Analysis, DNA1201350440.060 Why?
Zirconium12021830.060 Why?
Sensitivity and Specificity12016150750.050 Why?
Quinolines220187340.050 Why?
Genome, Human1201444580.050 Why?
Radioisotopes120215250.050 Why?
Prevalence12016147440.050 Why?
Cyclin T12017200.050 Why?
Clinical Trials as Topic1201480700.040 Why?
Neoplasm Metastasis2202053910.040 Why?
Naphthalenes120181950.040 Why?
Cyclin-Dependent Kinase 912017770.040 Why?
Middle Aged420192164680.040 Why?
Azoxymethane12016330.040 Why?
Cohort Studies12019387320.040 Why?
Microsatellite Instability120206790.040 Why?
Retrospective Studies22021673200.040 Why?
Phenylurea Compounds120185510.040 Why?
Intestinal Neoplasms120163170.030 Why?
Mice, Transgenic22018100940.030 Why?
Prostate1202114320.030 Why?
RNA Polymerase II120175260.030 Why?
Antigen Presentation1201913640.030 Why?
Mice, Inbred NOD1201819740.030 Why?
Diamines12012560.030 Why?
Epithelial-Mesenchymal Transition120186900.030 Why?
Genes, myc120134030.030 Why?
Lymphocytes, Tumor-Infiltrating1201810520.030 Why?
Chromosomes, Human, Pair 8120134750.030 Why?
Organic Chemicals120122240.030 Why?
Benzothiazoles120122520.030 Why?
Ubiquitination120169960.030 Why?
High-Throughput Screening Assays120179340.030 Why?
Breast Neoplasms12018191530.030 Why?
Neoplasm Invasiveness1202037890.030 Why?
Quinazolines1201814180.030 Why?
Drug Utilization1201812480.030 Why?
Piperidines1201815120.030 Why?
Genetic Heterogeneity120137600.020 Why?
Risk Factors12016692780.020 Why?
Caenorhabditis elegans Proteins120168830.020 Why?
Tumor Microenvironment1202025030.020 Why?
Immunoblotting1201218400.020 Why?
Mice, Nude1201540400.020 Why?
HEK293 Cells1201744160.020 Why?
DNA Primers1201231210.020 Why?
Caenorhabditis elegans1201614330.020 Why?
Neovascularization, Pathologic1201827670.020 Why?
Drug Administration Schedule1201551820.020 Why?
Genetic Predisposition to Disease22020170710.020 Why?
Proto-Oncogene Proteins c-myc1201210420.020 Why?
Pyrimidines1201829090.020 Why?
Immunohistochemistry12020120950.020 Why?
Cell Cycle Proteins1201734710.020 Why?
Disease-Free Survival1201571950.020 Why?
Reverse Transcriptase Polymerase Chain Reaction1201251140.020 Why?
Survival Analysis12018107660.020 Why?
Drug Resistance, Neoplasm1201952650.020 Why?
Transcription, Genetic1201781300.010 Why?
Dose-Response Relationship, Drug12015116160.010 Why?
Aged, 80 and over22019593310.010 Why?
Flow Cytometry1201262300.010 Why?
Gene Expression Regulation, Neoplastic1201888950.010 Why?
T-Lymphocytes12018103290.010 Why?
Gene Expression1201381820.010 Why?
Female420193754590.010 Why?
Mice, Inbred C57BL12018234390.010 Why?
Liver1201576530.010 Why?
Cell Line12013171370.010 Why?
Carcinoma, Squamous Cell1201339810.010 Why?
Prospective Studies12021490710.010 Why?
Transcription Factors12017119100.010 Why?
Follow-Up Studies12019397370.010 Why?
Antineoplastic Combined Chemotherapy Protocols12018111150.010 Why?
Gene Expression Profiling1201396610.010 Why?
Treatment Outcome12013609910.010 Why?
Dietlein's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (174)
Explore
_
Co-Authors (25)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.